Evotec SE has extended and expanded its strategic neurodegeneration partnership with Bristol Myers Squibb. Evotec said that because the initial partnership was highly productive in generating a promising pipeline of discovery to clinical-stage programs, the two companies agreed to extend and expand the partnership for additional eight years with the goal to further broaden and deepen the strategic alliance. Evotec and Bristol Myers Squibb initiated the collaboration in 2016 to identify dis...